The historical rank and industry rank for European Medical Solutions's Pretax Margin % or its related term are showing as below:
STU:AS00'
s Pretax Margin % Range Over the Past 10 Years
Min: -15.83 Med: -0.67 Max: 3.82
Current: 3.82
STU:AS00's Pretax Margin % is ranked better than 75.03% of 945
companies
in the Biotechnology industry
Industry Median: -90.63
vs STU:AS00: 3.82
European Medical Solutions (STU:AS00) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
European Medical Solutions Pretax Margin % Related Terms
European Medical Solutions Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:AS00 vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, European Medical Solutions's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
European Medical Solutions Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, European Medical Solutions's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where European Medical Solutions's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
European Medical Solutions (STU:AS00) has a Pretax Margin % of 3.44% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on European Medical Solutions and its competitors. According to the industry distribution chart, European Medical Solutions ranks #236 out of 945 companies in the Biotechnology industry, placing it in the top 25%.
Is European Medical Solutions' Pretax Margin % too high?
European Medical Solutions' current Pretax Margin % is 3.44%. Based on the distribution chart, European Medical Solutions ranks #236 out of 945 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, European Medical Solutions has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does European Medical Solutions' Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, European Medical Solutions ranks #236 out of 945 companies for Pretax Margin %. This places European Medical Solutions in the top 25% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on European Medical Solutions and its competitors. European Medical Solutions's current Pretax Margin % is 3.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is European Medical Solutions stock overvalued right now?
European Medical Solutions (STU:AS00) has a current Pretax Margin % of 3.44%. The stock's GF Value™ is €8.11, compared to a current price of €4.72 — trading 41.8% below its estimated fair value. The current Pretax Margin % is 3.44%. European Medical Solutions' overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For European Medical Solutions (STU:AS00), the current Pretax Margin % is 3.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is European Medical Solutions (STU:AS00) Overvalued in 2026?
Based on GuruFocus' analysis, European Medical Solutions stock appears to be undervalued.
The current stock price of €4.72 is trading 41.8% below its estimated GF Value™ of €8.11.
Key valuation signals for STU:AS00:
Pretax Margin %: 3.44%
GF Value™: €8.11 vs. price of €4.72 (41.8% below fair value)
No single metric tells the full story. See the STU:AS00 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.
47GF Score
Get the complete analysis for STU:AS00
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:AS00 has been successfully added to your 
